May 19, 2023
As the global pharmaceutical landscape continues to transform at a breathtaking pace, it becomes crucial to examine the phenomenon that …
Sept. 20, 2021
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is a …
Feb. 11, 2021
A few decades ago, pharmaceutical giants did most of the discovery work in-house, along with every other work necessary to …
Jan. 13, 2020
Pharmaceutical companies are increasingly outsourcing research activities to academic and private contract research organizations (CROs) as a strategy to stay competitive …
Jan. 2, 2020
There is a plethora of analytics reports, including ones by Deloitte, DKV Global, and Ernst and Young, all pointing out …
Oct. 1, 2019
(This post first appeared in Forbes) Pioneered by expensive and cumbersome legacy electronic data interchange (EDI) systems, the B2B e-commerce …
Jan. 21, 2019
The first month of 2019 is not over yet, but there are already four major announcements about new research projects …
Oct. 8, 2018
(Last updated 08.10.2018) The type of artificial intelligence (AI) which scares some of the greatest minds, like Elon Musk and …
June 2, 2018
(Edited version of this post originally appeared in Forbes) “It is not the strongest of the species that survives, nor …
April 25, 2018
Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate …
Dec. 26, 2017
Investments in artificial intelligence (AI) for drug discovery are surging. Big Pharmas are throwing big bucks at AI. Sanofi signed …
